𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

✍ Scribed by Miloslavsky, E. M.; Specks, U.; Merkel, P. A.; Seo, P.; Spiera, R.; Langford, C. A.; Hoffman, G. S.; Kallenberg, C. G. M.; St.Clair, E. W.; Tchao, N. K.; Viviano, L.; Ding, L.; Sejismundo, L. P.; Mieras, K.; Iklé, D.; Jepson, B.; Mueller, M.; Brunetta, P.; Allen, N. B.; Fervenza, F. C.; Geetha, D.; Keogh, K.; Kissin, E. Y.; Monach, P. A.; Peikert, T.; Stegeman, C.; Ytterberg, S. R.; Stone, J. H.

Book ID
120716725
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
806 KB
Volume
65
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pulse Versus Daily Oral Cyclophosphamide
Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis
✍ de Groot, Kirsten 📂 Article 📅 2009 🏛 American College of Physicians 🌐 English ⚖ 236 KB

## Background: Current therapies for antineutrophil cytoplasmic antibody (anca)-associated vasculitis are limited by toxicity. ## Objective: To compare pulse cyclophosphamide with daily oral cyclophosphamide for induction of remission. ## Design: Randomized, controlled trial. random assignments